Navigation Links
Roche Diabetes Care Forms Human Blue Circle, Supports Viral Video for World Diabetes Day
Date:11/11/2010

INDIANAPOLIS, Nov. 11, 2010 /PRNewswire/ -- Roche Diabetes Care, makers of ACCU-CHEK® products and services, is showing its support for World Diabetes Day (Nov. 14) through two truly collaborative initiatives.

(Photo: http://photos.prnewswire.com/prnh/20101111/DE99363)

(Photo: http://www.newscom.com/cgi-bin/prnh/20101111/DE99363)

Roche Diabetes Care formed its first human blue circle this year as a demonstration of support for people around the world with diabetes. The blue circle is the official logo of World Diabetes Day and is often duplicated in "human form" as a demonstrable act of support for WDD's effort to increase diabetes advocacy and awareness. Nearly 200 Roche employees formed the blue circle, which can be viewed on the ACCU-CHEK World Diabetes Day page.*

Roche Diabetes Care is also proud to have partnered with the Diabetes Hands Foundation, Diabetes Daily and Diabetes Stories to sponsor a video for the Big Blue Test. The video, located at http://www.youtube.com/watch?v=nkLHgK94Z0E, encourages people with diabetes to test their blood sugar on Nov. 14, get active for 14 minutes and then test again. The Big Blue Test, now in its second year, helps people with diabetes better understand the positive impact they can have on their blood sugar. Roche Diabetes Care underwrote the cost of the video's production and will make a donation for every view the video receives up to $75,000.

"The two initiatives underscore Roche's commitment to advocacy, awareness and education when it comes to diabetes," said Luc Vierstraete, senior vice president and general manager, Roche Diabetes Care North America. "We're thankful to have such wonderful partners in the diabetes community and hope that our Human Blue Circle and Big Blue Test video encourage others to get involved and make a difference in their communities."

World Diabetes Day is celebrated every year on Nov. 14 and was created by the International Diabetes Foundation and the World Health Organization. Since 2007 it has been recognized as an official United Nations Day.

* Publications may use the high-quality image attached to this release or e-mail todd.siesky@roche.com for an publish-ready image.

About Roche Diabetes CareRoche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 30 years, Roche has been committed to helping people with diabetes live lives that are as normal and active as possible and has been helping healthcare professionals manage their patients' condition in an optimal way. Today, the ACCU-CHEK portfolio offers people with diabetes and healthcare professionals innovative products, services and comprehensive solutions for convenient, efficient and effective diabetes management—from blood glucose monitoring through information management to insulin delivery. The ACCU-CHEK brand encompasses blood glucose meters, infusion pumps, lancing and data management systems. For more information, please visit accu-chek.com.

About RocheHeadquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2009, Roche had over 80,000 employees worldwide and invested almost 10 billion Swiss francs in R&D. The Group posted sales of 49.1 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com or www.roche-diagnostics.us.

All trademarks used or mentioned in this release are protected by law.For further information, please contact: Todd Siesky Public Relations ManagerRoche Diabetes CareIndianapolis, IN(317) 521-3966 O(317) 361-7637 Ctodd.siesky@roche.com
'/>"/>

SOURCE Roche Diabetes Care
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Heiner Dreismann, Ph.D., Former President of Roche Molecular Systems, Joins the HistoRx Board of Directors
2. InterMune Sells Danoprevir Rights to Roche for $175 Million
3. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
4. Sanford Rose Associates(R)-Rochester Named Top Office
5. Pfizer, Merck, Roche/Genentech, GSK, J&J, BMS and More to Speak at Contracting & Outsourcing 2010
6. Roche Diabetes Care and ICW Announce Technology Partnership
7. International Society for Cellular Therapy (ISCT) joins forces with Roche and Genzyme to launch Cell Therapy Industry Partnership.
8. X-Chem and Roche Enter Into Drug Discovery Collaboration and License Agreement
9. QIAGEN and Roche Settle Dispute Over Distribution Agreement for TheraScreen Companion Diagnostics
10. Cellular Dynamics and Roche Conduct Stem Cells in Drug Discovery and Development Workshop at the Society of Toxicology Annual Meeting
11. EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... Lajollacooks4u is proud to announce it has become the premiere team-building ... challenges for companies around the world, such as Illumina, HP and Qualcomm, and is ranked ... its increasing popularity is due to its new team building format, a way for teams ...
(Date:3/23/2017)... 2017  Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), ... for solid tumor cancers, today announced that yesterday ... announced last Friday, March 17, 2017. ... securities totaling 28,843,692 shares, comprised of 18,843,692 common ... of Class C Warrants pre-funded at the closing ...
(Date:3/23/2017)...  GlobeImmune, Inc. today announced it has entered into ... shares of its common stock to NantCell, Inc., a ... the sale of its common stock, NantCell has agreed ... GlobeImmune 200,000 shares, an estimated $2.0 million in value, ... pleased to enter into this strategic agreement with NantCell," ...
(Date:3/23/2017)... Branford, CT (PRWEB) , ... March 23, 2017 ... ... Counsel, LLC, was recently selected by the Connecticut Technology Council (CTC) as a ... honored at CTC’s thirteenth annual Women of Innovation Awards Dinner. , The dinner ...
Breaking Biology Technology:
(Date:3/13/2017)... , March 13, 2017 Future of security: Biometric Face ... ... DERMALOGs Face Matching enables to match face pictures against ... basis to identify individuals. (PRNewsFoto/Dermalog Identification Systems) ... DERMALOG,s "Face Matching" is the fastest software for biometric Face Matching ...
(Date:3/7/2017)... CITY , March 7, 2017   HireVue ... help top global companies identify the best talent, faster, ... as Chief Sales Officer (CSO) and Diana Kucer ... appointments round out a seasoned executive team poised to drive ... beyond, building on a year of record bookings in ...
(Date:3/2/2017)... LONDON , March 2, 2017 Who ... infringement lawsuits? Download the full report: https://www.reportbuyer.com/product/4313699/ ... ON THE FINGERPRINT SENSOR FIELD? Fingerprint sensors using ... smartphones. The fingerprint sensor vendor Idex forecasts an increase ... in mobile devices and of the fingerprint sensor market ...
Breaking Biology News(10 mins):